Department of Biochemistry
-
June 17, 2015
Lit up COX-2 cancer probe
A new imaging probe developed by Vanderbilt investigators enhances tumor visibility and has broad applications in diagnosing and monitoring patients with cancer. -
June 4, 2015
Study identifies C. diff toxin receptor, suggests new treatment approaches
Vanderbilt University investigators have identified a cellular receptor for a toxin from Clostridium difficile (“C. diff”) — the leading cause of hospital-acquired diarrhea in the United States. -
April 28, 2015
David Ong, professor of Biochemistry, emeritus, dies at 71
David E. Ong, Ph.D., professor of Biochemistry, emeritus, whose contributions to research in the area of vitamin A biochemistry were recognized worldwide, died April 25. He was 71. -
March 5, 2015
Vanderbilt team first to blend high-end imaging techniques
Vanderbilt University researchers have achieved the first “image fusion” of mass spectrometry and microscopy — a technical tour de force that could, among other things, dramatically improve the diagnosis and treatment of cancer. -
February 26, 2015
Center for Structural Biology symposium to feature stellar lineup
The Vanderbilt University Department of Biochemistry will host a two-day symposium March 6-7 to honor the 60th birthday of Walter Chazin, Ph.D., director of the Center for Structural Biology. -
February 25, 2015
Antibiotics with anticancer potential
A series of experimental antibiotics may be a good starting point for developing new anticancer drugs. -
January 29, 2015
Grant bolsters pancreatic cancer drug discovery efforts
The Lustgarten Foundation has awarded a $1.5 million Research Investigator Grant to Stephen Fesik, Ph.D., professor of Biochemistry, Pharmacology and Chemistry, for research designed to discover new drugs for the treatment of pancreatic cancer.